Before a single sterile dose is compounded, the pharmacy cleanroom suite has to prove — by measured, witnessed, documented test — that it performs to the engineered intent. This Article covers the acceptance discipline that turns a constructed cleanroom into an operational one: the commissioning sequence, the certification tests that establish ISO air classification and pressure cascade, the viable and non-viable environmental sampling program, and the documentation and recertification cadence that keeps the suite compliant after go-live.

This article is about verification and acceptance, not design. The way the cleanroom is built — HVAC architecture, HEPA placement, pressure-cascade engineering, room construction under USP General Chapters <797> and <800> — is covered in the cleanrooms-and-clinical-requirements and building-systems siblings. Here the question is narrower and harder: does it pass, who says so, what evidence do we keep, and how often must we re-prove it.

Why certification is the hard activation gate

A pharmacy cleanroom is the only space in a hospital that is, in effect, a small pharmaceutical-manufacturing facility. The acceptance bar is correspondingly high and is enforced by multiple overlapping authorities:

• USP <797> (sterile compounding) and USP <800> (hazardous-drug handling) set the certification frequency, the air-classification targets by compounding area, and the environmental-monitoring requirements. The 2023 revision of <797> is enforceable and tightened several of these.
• The State Board of Pharmacy is the operational licensing authority and frequently incorporates the USP chapters by reference; many boards will not issue or renew a sterile-compounding permit without current certification reports on file.
• The Joint Commission (TJC) or DNV survey the medication-management and environment-of-care standards, including evidence that the cleanroom certification and monitoring program is active and current.
• CMS Conditions of Participation flow down through the accrediting organization; deficiencies in sterile-compounding controls surface as medication-management findings.
• The AHJ (authority having jurisdiction) and the building/life-safety codes — FGI Guidelines, ASHRAE 170, NFPA 99/101, IBC occupancy — govern the base-building commissioning that the cleanroom certification sits on top of (airflow, pressure, electrical, life safety). FGI sets the planning and ventilation requirements that ASHRAE 170 quantifies.

The practical consequence: certification is not a one-time construction milestone. It is a recurring obligation that begins at commissioning and never ends. A facility that passes initial certification but lets recertification lapse is just as out of compliance as one that never certified at all — and the lapse is the more common real-world failure.

The commissioning-to-certification sequence

Commissioning and certification are distinct activities that must run in the right order. Base-building commissioning proves the systems; cleanroom certification proves the space performs as a classified environment; the environmental sampling program then proves the space stays clean in use. Compressing or overlapping these phases is the single most common cause of go-live delay.

A typical sequence:

1. Construction substantial completion of the cleanroom shell, finishes, HVAC, and utilities. Finishes must be the cleanroom-rated, cleanable, monolithic surfaces specified — certification cannot be run against incomplete or temporary finishes.
2. Base-building / HVAC commissioning (Cx). The mechanical system is balanced and verified: air-handling units, terminal HEPA modules, supply/exhaust airflow, the pressure-cascade setpoints, temperature and humidity control, and the building-automation/monitoring integration. Test-and-balance (TAB) is completed and signed.
3. Cleanroom certification testing by a qualified certifier (see below), run at-rest first, then confirmed in operation once equipment and process flow are in place.
4. Environmental sampling baseline — initial viable air, surface, and (per <800>) wipe sampling to establish the clean-state baseline before patient-facing compounding.
5. Operational readiness / dry-run of staffing, gowning, and workflow (covered in the operational-readiness sibling) — which itself relies on a certified, monitored room.
6. Board of Pharmacy / accreditation sign-off with certification reports and the monitoring plan on file.
7. Go-live, with the recertification clock and monitoring cadence now running.